Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Exceptional extension!
Enjoy this offer
* See conditions under "Our services"

Valuation: Ipsen

Market Cap 12.91B 14.77B 11.94B 11.14B 20.92B 1,396B 21.07B 142B 55.2B 686B 55.45B 54.25B 2,384B P/E 2026 *
14.5x
P/E 2027 * 14.2x
Enterprise Value 11.54B 13.21B 10.68B 9.97B 18.71B 1,249B 18.85B 127B 49.37B 614B 49.6B 48.53B 2,132B EV / Sales 2026 *
2.71x
EV / Sales 2027 * 2.36x
Free-Float
40.65%
Yield 2026 *
0.91%
Yield 2027 * 0.94%
1 day+1.46%
1 week+1.48%
Current month+0.77%
1 month-2.72%
3 months+6.92%
6 months+31.77%
Current year+32.77%
1 week 151.7
Extreme 151.7
162.8
1 month 148.8
Extreme 148.8
162.8
Current year 116
Extreme 116
176.6
1 year 101.1
Extreme 101.1
176.6
3 years 88.05
Extreme 88.05
176.6
5 years 77.28
Extreme 77.28
176.6
10 years 35.52
Extreme 35.52
176.6
Manager TitleAgeSince
Chief Executive Officer 59 01/07/2020
Chief Executive Officer 57 01/01/2020
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member 61 30/08/2005
Chairman 68 22/11/2010
Director/Board Member 69 01/06/2012
Change 5-day change 1-year change 3-year change Capi.($)
+1.46%+1.48% - - 14.77B
+0.32%-2.41%+44.49%+140.80% 983B
+1.27%-1.85%+54.41%+39.65% 557B
+6.25%+3.80%+24.13%+67.39% 406B
+1.55%-1.93%+23.33%+16.35% 314B
+1.46%+1.08%+28.87%+17.56% 273B
+1.33%+1.75%+28.10%+34.30% 272B
+1.66%+8.85%-32.30%-43.94% 203B
+2.11%-1.66%+19.14%+50.10% 186B
+0.90%+0.46%+15.09%+59.86% 155B
Average +1.83%-0.92%+22.81%+42.45% 372.26B
Weighted average by Cap. +1.69%-2.22%+31.65%+64.71%

Financials

2026 *2027 *
Net sales 4.25B 4.87B 3.93B 3.67B 6.89B 460B 6.94B 46.75B 18.19B 226B 18.28B 17.88B 786B 4.47B 5.11B 4.13B 3.86B 7.24B 483B 7.3B 49.13B 19.11B 238B 19.2B 18.79B 826B
Net income 923M 1.06B 854M 797M 1.5B 99.83B 1.51B 10.15B 3.95B 49.08B 3.97B 3.88B 171B 938M 1.07B 867M 810M 1.52B 101B 1.53B 10.31B 4.01B 49.86B 4.03B 3.94B 173B
Net Debt -1.36B -1.56B -1.26B -1.18B -2.21B -147B -2.22B -14.97B -5.82B -72.42B -5.85B -5.72B -252B -2.37B -2.71B -2.19B -2.05B -3.84B -257B -3.87B -26.07B -10.14B -126B -10.19B -9.97B -438B
Logo Ipsen
Ipsen specialises in the research, development, manufacture and marketing of specialty medicines. Net sales by therapeutic area break down as follows: - oncology (69.2%); - neuroscience (20.3%); - rare diseases (10.5%). At the end of 2025, the group had 7 research and development centers located in France (2), the United Kingdom (2), China (2) and Ireland, and 5 manufacturing sites worldwide. Net sales are distributed geographically as follows: France (8%), Europe (31.7%), the United States (32.9%), North America (2.2%) and other (25.2%).
Employees
5,535
Date Price Change Volume
23/06/26 157.60 +0.38% 0
22/06/26 156.60 +0.06% 239,217
19/06/26 156.50 +1.69% 63,842
18/06/26 153.90 -2.78% 68,738
17/06/26 158.30 +1.93% 598
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
15
Last Close Price
157.20EUR
Average target price
160.00EUR
Spread / Average Target
+1.78%

Quarterly revenue - Rate of surprise

-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!